Future directions in myoma research

Obstetrics and Gynecology Clinics of North America

Volumn 33, Issue 1, 2006, Pages 199-224

  Brahma, Pavna K ^a   Martel, Kristina M ^a   Christman, Gregory M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ANGIOPEPTIN; ANTIGESTAGEN; AROMATASE INHIBITOR; ASOPRISNIL; BASIC FIBROBLAST GROWTH FACTOR; CETRORELIX; CONJUGATED ESTROGEN; CYTOKINE; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE INHIBITOR; ESTROGEN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GESTAGEN; GONADORELIN AGONIST; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT; PROGESTERONE RECEPTOR; PROGESTERONE RECEPTOR MODULATOR; SEX HORMONE; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE; TAMOXIFEN;

AMENORRHEA; BREAKTHROUGH BLEEDING; CANCER GENETICS; CANCER RESEARCH; CLINICAL TRIAL; CYTOKINE RELEASE; DISEASE EXACERBATION; ENDOMETRIUM ABLATION; ENDOMETRIUM HYPERPLASIA; EXTRACELLULAR MATRIX; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; HYPOESTROGENISM; HYSTERECTOMY; LEIOMYOMA; MYOMECTOMY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SIDE EFFECT; SURGICAL TECHNIQUE; ULTRASOUND THERAPY; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA;

FEMALE; FORECASTING; HUMANS; LEIOMYOMA; RESEARCH DESIGN; UTERINE NEOPLASMS;

EID: 33644510444     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2005.12.011     Document Type: Review

References (115)

1. S.F. Cramer, and A. Patel The frequency of uterine leiomyomas Am J Clin Pathol 94 1990 435 438
2. V.J. Buttram, and R. Reiter Uterine leiomyomata: etiology, symptomatology, and management Fertil Steril 36 1981 433 445
3. K. Kjerulff, P. Langenberg, and J. Seidman Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis J Reprod Med 41 7 1996 483 490
4. L. Marshall, D. Spiegelman, and R. Barbieri Variation in the incidence of uterine leiomyoma among premenopausal women by age and race Obstet Gynecol 90 6 1997 967 973
5. G.P. Flake, J. Andersen, and D. Dixon Etiology and pathogenesis of uterine leiomyomas: a review Environ Health Perspect 111 8 2003 1037 1054
6. S.M. Schwartz, L.M. Marshall, and D.D. Baird Epidemiologic contributions to understanding the etiology of uterine leiomyomata Environ Health Perspect 108 Suppl 5 2000 821 827
7. C. Walker, K. Cesen-Cummings, and C. Houle Protective effect of pregnancy for development of uterine leiomyoma Carcinogenesis 22 12 2001 2049 2052
8. F. Chiaffarino, F. Parazzini, and C. La Vecchia Diet and uterine myomas Obstet Gynecol 94 3 1999 395 398
9. L. Marshall, D. Spiegelman, and J. Manson Risk of uterine leiomyomata among premenopausal women in relation to body size and cigarette smoking Epidemiology 9 1998 511 517
10. L.A. Wise, J.R. Palmer, and D. Spiegelman Influence of body size and body fat distribution on risk of uterine leiomyomata in US black women Epidemiology 16 3 2005 346 354
11. L.A. Wise, J.R. Palmer, and B.L. Harlow Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study Hum Reprod 19 8 2004 1746 1754
12. C. Walker, and E. Stewart Uterine fibroids: the elephant in the room Science 308 2005 1589 1592
13. A. Sandberg Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: leiomyoma Cancer Genet Cytogen 158 2004 1 26
14. N. Alam, A. Rowan, and N. Wortham Genetic and functional analysis of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency Hum Mol Genet 12 11 2003 1241 1252
15. N. Alam, S. Bevan, and M. Churchman Localization of a gene (MCUL1) for multiple cutaneous leiomyomata and uterine fibroids to chromosome 1q42.3q43 Am J Hum Genet 68 2001 1264 1269
16. J. Toro, M. Nickerson, and M. Wei Mutations in the Fumarate Hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America Am J Hum Genet 73 2003 95 106
17. J. Andersen, and R.L. Barbieri Abnormal gene expression in uterine leiomyomas J Soc Gynecol Investig 2 5 1995 663 672
18. C.L. Walker, and E.A. Stewart Uterine fibroids: the elephant in the room Science 308 5728 2005 1589 1592
19. T. Maruo, N. Ohara, and J. Wang Sex steroidal regulation of uterine leiomyoma growth and apoptosis Hum Reprod Update 10 3 2004 207 220
20. A. Al-Hendy, E.J. Lee, and H.Q. Wang Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice Am J Obstet Gynecol 191 5 2004 1621 1631
21. A.J. Jakimiuk, M. Bogusiewicz, and R. Tarkowski Estrogen receptor alpha and beta expression in uterine leiomyomas from premenopausal women Fertil Steril 82 Suppl 3 2004 1244 1249
22. J. Andersen Comparing regulation of the connexin43 gene by estrogen in uterine leiomyoma and pregnancy myometrium Environ Health Perspect 108 Suppl 5 2000 811 815
23. J. Andersen, V.M. DyReyes, and R.L. Barbieri Leiomyoma primary cultures have elevated transcriptional response to estrogen compared with autologous myometrial cultures J Soc Gynecol Investig 2 3 1995 542 551
24. J.D. Cook, and C.L. Walker Treatment strategies for uterine leiomyoma: the role of hormonal modulation Semin Reprod Med 22 2 2004 105 111
25. J. Steinauer, E.A. Pritts, and R. Jackson Systematic review of mifepristone for the treatment of uterine leiomyomata Obstet Gynecol 103 6 2004 1331 1336
26. S.E. Bulun, E.R. Simpson, and R.A. Word Expression of the CYP19 gene and its product aromatase cytochrome P450 in human uterine leiomyoma tissues and cells in culture J Clin Endocrinol Metab 78 3 1994 736 743
27. H. Sumitani, M. Shozu, and T. Segawa In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism Endocrinology 141 10 2000 3852 3861
28. M. Shozu, H. Sumitani, and T. Segawa Inhibition of in situ expression of aromatase P450 in leiomyoma of the uterus by leuprorelin acetate J Clin Endocrinol Metab 86 11 2001 5405 5411
29. H. Ishihara, J. Kitawaki, and N. Kado Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas Fertil Steril 79 Suppl 1 2003 735 742
30. M. Shozu, K. Murakami, and M. Inoue Aromatase and leiomyoma of the uterus Semin Reprod Med 22 1 2004 51 60
31. D. Dixon, H. He, and J.K. Haseman Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium Environ Health Perspect 108 Suppl 5 2000 795 802
32. K. Englund, B. Lindblom, and K. Carlstrom Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions Mol Hum Reprod 6 10 2000 915 920
33. K.D. Burroughs, S.R. Howe, and Y. Okubo Dysregulation of IGF-I signaling in uterine leiomyoma J Endocrinol 172 1 2002 83 93
34. T. Maruo, H. Matsuo, and Y. Shimomura Effects of progesterone on growth factor expression in human uterine leiomyoma Steroids 68 10-13 2003 817 824
35. A. Di Lieto, F. Iannotti, and M. De Falco Immunohistochemical detection of insulin-like growth factor type I receptor and uterine volume changes in gonadotropin-releasing hormone analog-treated uterine leiomyomas Am J Obstet Gynecol 188 3 2003 702 706
36. X. Wu, H. Wang, and K. Englund Expression of progesterone receptors A and B and insulin-like growth factor-I in human myometrium and fibroids after treatment with a gonadotropin-releasing hormone analogue Fertil Steril 78 5 2002 985 993
37. C.D. Swartz, C.A. Afshari, and L. Yu Estrogen-induced changes in IGF-I, Myb family and MAP kinase pathway genes in human uterine leiomyoma and normal uterine smooth muscle cell lines Mol Hum Reprod 11 6 2005 441 450
38. T. Yamada, S. Nakago, and O. Kurachi Progesterone down-regulates insulin-like growth factor-I expression in cultured human uterine leiomyoma cells Hum Reprod 19 4 2004 815 821
39. J. Wang, N. Ohara, and S. Takekida Comparative effects of heparin-binding epidermal growth factor-like growth factor on the growth of cultured human uterine leiomyoma cells and myometrial cells Hum Reprod 20 6 2005 1456 1465
40. W. Chen, S. Yoshida, and N. Ohara Gonadotropin-releasing hormone antagonist cetrorelix down-regulates proliferating cell nuclear antigen and epidermal growth factor expression and up-regulates apoptosis in association with enhanced poly(adenosine 5′-diphosphate-ribose) polymerase expression in cultured human leiomyoma cells J Clin Endocrinol Metab 90 2 2005 884 892
41. A. Shushan, N. Rojansky, and N. Laufer The AG1478 tyrosine kinase inhibitor is an effective suppressor of leiomyoma cell growth Hum Reprod 19 9 2004 1957 1967
42. A. Arici, and I. Sozen Expression, menstrual cycle-dependent activation, and bimodal mitogenic effect of transforming growth factor-beta1 in human myometrium and leiomyoma Am J Obstet Gynecol 188 1 2003 76 83
43. B.S. Lee, and R.A. Nowak Human leiomyoma smooth muscle cells show increased expression of transforming growth factor-beta 3 (TGF beta 3) and altered responses to the antiproliferative effects of TGF beta J Clin Endocrinol Metab 86 2 2001 913 920
44. A. Arici, and I. Sozen Transforming growth factor-beta3 is expressed at high levels in leiomyoma where it stimulates fibronectin expression and cell proliferation Fertil Steril 73 5 2000 1006 1011
45. X. Wu, A. Blanck, and M. Olovsson Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment Acta Obstet Gynecol Scand 80 6 2001 497 504
46. C. Poncelet, P. Madelenat, and G. Feldmann Expression of von Willebrand's factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas Fertil Steril 78 3 2002 581 586
47. I. Sozen, and A. Arici Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of uterine leiomyomata Fertil Steril 78 1 2002 1 12
48. E.A. Stewart, A.J. Friedman, and K. Peck Relative overexpression of collagen type I and collagen type III messenger ribonucleic acids by uterine leiomyomas during the proliferative phase of the menstrual cycle J Clin Endocrinol Metab 79 3 1994 900 906
49. P.C. Leppert, T. Baginski, and C. Prupas Comparative ultra structure of collagen fibrils in uterine leiomyomas and normal myometrium Fertil Steril 82 Suppl 3 2004 1182 1187
50. Y.Y. Hsieh, C.C. Chang, and C.W. Hsu Gene transfection with p53 and p21 inhibit cell proliferation, collagen type I, leukemia inhibitory factor, and tumor necrosis factor-alpha expression in leiomyoma cells Fertil Steril 81 6 2004 1665 1670
51. Y. Wegrowski, G. Bellon, and C. Quereux Biochemical alterations of uterine leiomyoma extracellular matrix in type IV Ehlers-Danlos syndrome Am J Obstet Gynecol 180 4 1999 1032 1034
52. L. Ding, J. Xu, and X. Luo Gonadotropin releasing hormone and transforming growth factor beta activate mitogen-activated protein kinase/extracellularly regulated kinase and differentially regulate fibronectin, type I collagen, and plasminogen activator inhibitor-1 expression in leiomyoma and myometrial smooth muscle cells J Clin Endocrinol Metab 89 11 2004 5549 5557
53. M. Wolanska, K. Sobolewski, and M. Drozdzewicz Extracellular matrix components in uterine leiomyoma and their alteration during the tumour growth Mol Cell Biochem 189 1-2 1998 145 152
54. A.G. Berto, S.M. Oba, and Y.M. Michelacci Galactosaminoglycans from normal myometrium and leiomyoma Braz J Med Biol Res 34 5 2001 633 637
55. T.N. Mitropoulou, and K.D. Stagiannis Variation in sulfation pattern of galactosaminoglycan containing proteoglycans is associated with the development of uterine leiomyoma Biomed Chromatogr 18 7 2004 411 413
56. A.G. Berto, L.O. Sampaio, and C.R. Franco A comparative analysis of structure and spatial distribution of decorin in human leiomyoma and normal myometrium Biochim Biophys Acta 1619 1 2003 98 112
57. W.H. Catherino, P.C. Leppert, and M.H. Stenmark Reduced dermatopontin expression is a molecular link between uterine leiomyomas and keloids Genes Chromosomes Cancer 40 3 2004 204 217
58. Q. Dou, R.W. Tarnuzzer, and R.S. Williams Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumour regression Mol Hum Reprod 3 11 1997 1005 1014
59. D. Day Baird, D. Dunson, and M. Hill High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence Am J Obstet Gynecol 188 1 2003 100 107
60. R. Ross, M. Pike, and M. Vessey Risk factors for uterine fibroids: reduced risk associated with oral contraceptives Br Med J (Clin Res Ed) 293 6553 1986 1027
61. L. Marshall, D. Spiegelman, and M. Goldman A prospective study of reproductive factors and oral contraceptive use in relation to the risk of uterine leiomyomata Fertil Steril 70 3 1998 432 439
62. E. Stewart Uterine fibroids Lancet 357 9252 2001 293 298
63. S. Treloar, N. Martin, and L. Dennerstein Pathways to hysterectomy: insights from longitudinal twin research Am J Obstet Gynecol 167 1 1992 82 88
64. J. Steinauer, E. Pritts, and R. Jackson Systematic review of mifepristone for the treatment of uterine leiomyomata Obstet Gynecol 103 2004 1331 1336
65. S. Goodwin, and W. Walker Uterine artery embolization for the treatment of uterine fibroids Curr Opin Obstet Gynecol 10 1998 315
66. F.J. Hutchins, R. Worthington-Kirsch, and R. Berkowitz Selective uterine artery embolization as primary treatment for symptomatic leiomyomata uteri J Am Assoc Gynecol Laparosc 6 1999 279
67. J. Ravina, D. Herbreteau, and N. Ciraru-Vigneron Arterial embolization to treat uterine myomas Lancet 346 8976 1995 671 672
68. J. Spies, S. Ascher, and A. Roth Uterine artery embolization for leiomyomata Obstet Gynecol 98 1 2001 29 34
69. R. Worthington-Kirsch, G. Popky, and F.J. Hutchins Uterine arterial embolization for the management of leiomyomas: quality-of-life assessment and clinical response Radiology 208 3 1998 625 629
70. G. Lefebvre, G. Vilos, M. Asch Society of Obstetricians and Gynaecologists of Canada: Canadian Association of Radiologists: Canadian Interventional Radiology Association Uterine fibroid embolization (UFE) J Obstet Gynaecol Can 26 10 2004 899 911
71. P. Burn, J. McCall, and R. Chinn Uterine fibroleiomyoma: MR imaging appearances before and after embolization of uterine arteries Radiology 214 3 2000 729 734
72. R. Jha, S. Ascher, and I. Imaoka Symptomatic fibroleiomyomata: MR imaging of the uterus before and after uterine arterial embolization Radiology 217 2000 228
73. G. Pron, J. Bennett, and A. Common The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids Fertil Steril 79 1 2003 120 127
74. J. Spies, A. Spector, and A. Roth Complications after uterine artery embolization for leiomyomas Obstet Gynecol 100 5 Pt 1 2002 873 880
75. W. Walker, and J. Pelage Uterine artery embolization for symptomatic fibroids: clinical results in 400 women with imaging follow up BJOG 109 2002 1262
76. G. Watson, and W. Walker Uterine artery embolization for the treatment of symptomatic fibroids in 114 women: reduction in size of the fibroids and women's views of the success of the treatment BJOG 109 2002 129
77. J. Spies, A. Scialli, and R. Jha Initial results from uterine fibroid embolization for symptomatic leiomyomata J Vasc Interv Radiol 10 9 1999 1145 1147
78. G. Siskin, B. Stainken, and K. Dolwing Outpatient uterine artery embolization for symptomatic uterine fibroids: experience in 49 patients J Vasc Interv Radiol 11 2000 305 311
79. G. Vilos Side effects and complications of embolization I. Tulansi Uterine fibroids: embolization and other treatments 2003 Cambridge University Press Cambridge (UK) 111 118
80. H. Chrisman, M. Saker, and R. Ryu The impact of uterine fibroid embolization on resumption of menses and ovarian function J Vasc Interv Radiol 11 6 2000 699 703
81. B. Hurst, D. Stackhouse, and M. Matthews Uterine artery embolization for symptomatic uterine myomas Fertil Steril 74 2000 855
82. J. Pelage, O. Le Dref, and P. Soyer Fibroid-related menorrhagia: treatment with super selective embolization of the uterine arteries and midterm follow-up Radiology 218 2 2001 605 606
83. J. Spies, A. Roth, and S. Gonsalves Ovarian function after uterine artery embolization for leiomyomata: assessment with use of serum follicle stimulating hormone assay J Vasc Interv Radiol 12 2001 437
84. I. Honda, T. Sato, and H. Adachi Uterine artery embolization for leiomyoma: complications and effects on fertility Nippon Igaku Hoshasen Gakkai Zasshi 63 6 2003 294 302
85. Agency for Health Care and Research Quality. Management of Uterine Fibroids. Paper presented at the Summary, Evidence Report/Technology Assessment. Rockville (MD), January 2001
86. S. Leibsohn, G. d'Ablaing, and D.J. Mishell Leiomyosarcoma in a series of hysterectomies performed for presumed uterine leiomyomas Am J Obstet Gynecol 162 1990 196
87. K. Kjerulff, P. Langenberg, and J. Rhodes Effectiveness of hysterectomy Obstet Gynecol 95 3 2000 319 326
88. E. Stewart, A. Faur, and L. Wise Predictors of subsequent surgery for uterine leiomyomata after abdominal myomectomy Obstet Gynecol 99 3 2002 426 432
89. P. Acien, and F. Quereda Abdominal myomectomy: results of a simple operative technique Fertil Steril 65 1996 41
90. V.J. Buttram Uterine leiomyomata-etiology, symptomatology and management Prog Clin Bio Res 225 1986 275
91. L. Fedele, F. Parazzini, and L. Luchini Recurrence of fibroids after myomectomy: a transvaginal ultrasonographic study Hum Reprod 10 7 1995 1795 1796
92. M. Hanafi Predictors of leiomyoma recurrence after myomectomy Obstet Gynecol 105 4 2005 877 881
93. L. Malone Myomectomy: recurrence after removal of solitary and multiple myomas Obstet Gynecol 34 1969 200
94. J. Dubuisson, A. Fauconnier, and V. Fourchotte Laparoscopic myomectomy: predicting the risk of conversion to an open procedure Hum Reprod 16 8 2001 1726 1731
95. J. Dubuisson, A. Fauconnier, and J. Deffarges Pregnancy outcome and deliveries following laparoscopic myomectomy Hum Reprod 15 4 2000 869 873
96. J. Garnet Uterine rupture during pregnancy. An analysis of 133 patients Obstet Gynecol 23 1964 898
97. N. Stotland, L. Lipschitz, and A. Caughey Delivery strategies for women with a previous classic cesarean delivery: a decision analysis Am J Obstet Gynecol 187 2002 1203
98. S. Hockstein Spontaneous uterine rupture in the early third trimester after laparoscopically assisted myomectomy. A case report J Reprod Med 45 2000 139
99. C. Nezhat The "cons" of laparoscopic myomectomy in women who may reproduce in the future Int J Fertil Menopausal Stud 41 1996 280
100. S. Derman, J. Rehnstrom, and R. Neuwirth The long-term effectiveness of hysteroscopic treatment of menorrhagia and leiomyomas Obstet Gynecol 77 1991 591
101. S. Arcangeli, and M. Pasquarette Gravid uterine rupture after myolysis Obstet Gynecol 89 1997 857
102. J. Hindley, P. Law, and M. Hickey Clinical outcomes following percutaneous magnetic resonance image guided laser ablation of symptomatic uterine fibroids Hum Reprod 17 10 2002 2737 2741
103. E. Stewart, W. Gedroyc, and C. Tempany Focused ultrasound treatment of uterine fibroid tumors: safety and feasibility of a noninvasive thermoablative technique Am J Obstet Gynecol 189 1 2003 48 54
104. J. Hoppener, S. Mosselman, and P. Roholl Expression of insulin-like growth factor I and II genes in human smooth muscle tumors EMBO J 7 1988 1379 1385
105. K. Boehm, M. Daimon, and I. Gorodeski Expression of the insulin-like growth factor genes in human uterine tissues Mol Reprod Dev 27 1990 93 101
106. G. Norstedt, A. Levionvitz, and H. Ericksson Regulation of uterine insulin-like growth factor I mRNA and insulin-like growth factor II mRNA by estrogen in the rat Acta Endocrinol (Copenh) 120 1989 466 472
107. M. Rein, A. Freidman, and M. Pandian The secretion of insulin-like growth factor-I and II by explant cultures of fibroids and myometrium from women treated with gonadotropin-releasing hormone agonist Obstet Gynecol 76 1990 388 394
108. J. Kuhn, C. Basin, and M. Mollard Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analogue BIM 23014 Eur J Clin Pharmacol 45 1 1993 73 77
109. O. Choen, B. Schindel, and R. Homburg Uterine leiomyomata-a feature of acromegaly Hum Reprod 13 1998 1945 1946
110. V. De Leo, A. la Marca, and G. Morgante Administration of somatostatin analogue reduces uterine and myoma volume in women with uterine leiomyomata Fertil Steril 75 2001 632 633
111. F. Raulf, J. Perez, and D. Hoyer Differential expression of five somatostatin receptor subtypes, SSTR1-5 in the CNS and peripheral tissue Digestion 55 1994 46 53
112. K. Chwalisz, D. Demanno, and R. Garg Therapeutic potential for the selective progesterone receptor modulator asoprisnil in the treatment of leioyomata Semin Reprod Med 22 2004 113 119
113. D. DeManno, W. Elger, and R. Garg Asoprisnil (J867): a selective progesterone receptor modulator for gynecological therapy Steroids 68 2003 1019 1032
114. M. Shozu, K. Murakami, and T. Segawa Successful treatment of a symptomatic uterine leiomyoma in a perimenopausal woman with a nonsteroidal aromatase inhibitor Fertil Steril 79 2003 628 631
115. L. Hansen, F. Batzer, and S. Corson Obesity and GnRH action. Report of a case with contribution by peripherally derived estrogens J Reprod Med 42 1997 247 250